Search research articles
Contact Us
Filters
Showing results (21-30 of 191) with videos related to
Page
of 20
Sort By:
The Journal of Clinical Psychiatry
|
December 17, 2013
Dr McGorry and colleagues reply
Patrick D McGorry, Alison R Yung, Barnaby Nelson, et al.
Drug Testing and Analysis
|
October 23, 2020
A validated method for the simultaneous quantification of cannabidiol, Δ<sup>9</sup> -tetrahydrocannabinol, and their metabolites in human plasma and application to plasma samples from an oral cannabidiol open-label trial
Richard C Kevin, Rebecca Vogel, Peter Doohan, et al.
Psychiatry Research
|
May 17, 2015
Erythrocyte polyunsaturated fatty acid levels in young people at ultra-high risk for psychotic disorder and healthy adolescent controls
Simon M Rice, Miriam R Schäfer, Claudia Klier, et al.
Frontiers in Psychiatry
|
June 16, 2020
Commentary: Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence)
Barnaby Nelson, G Paul Amminger, Andrew Thompson, et al.
Biological Psychiatry
|
August 22, 2006
Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study
G Paul Amminger, Gregor E Berger, Miriam R Schäfer, et al.
Current Opinion in Psychiatry
|
June 7, 2007
Age of onset of mental disorders: a review of recent literature
Ronald C Kessler, G Paul Amminger, Sergio Aguilar-Gaxiola, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
|
April 5, 2017
Novel biotherapies are needed in youth mental health
G Paul Amminger, Maximus Berger, Simon M Rice, et al.
Schizophrenia Research
|
September 19, 2012
The Community Assessment of Psychic Experience (CAPE) questionnaire as a screening-instrument in the detection of individuals at ultra-high risk for psychosis
Nilufar Mossaheb, Jana Becker, Miriam R Schaefer, et al.
Schizophrenia Research
|
September 11, 2012
Social cognition in clinical "at risk" for psychosis and first episode psychosis populations
Andrew Thompson, Alicia Papas, Cali Bartholomeusz, et al.
Early Intervention in Psychiatry
|
October 28, 2014
Indicated prevention with long-chain polyunsaturated omega-3 fatty acids in patients with 22q11DS genetically at high risk for psychosis. Protocol of a randomized, double-blind, placebo-controlled treatment trial
Marco Armando, Franco De Crescenzo, Stefano Vicari, et al.
Page
of 20
Search research articles
Search
Showing results (21-30 of 191) with videos related to
Sort By:
Page
of 20
The Journal of Clinical Psychiatry
|
December 17, 2013
Dr McGorry and colleagues reply
Patrick D McGorry, Alison R Yung, Barnaby Nelson, et al.
Drug Testing and Analysis
|
October 23, 2020
A validated method for the simultaneous quantification of cannabidiol, Δ<sup>9</sup> -tetrahydrocannabinol, and their metabolites in human plasma and application to plasma samples from an oral cannabidiol open-label trial
Richard C Kevin, Rebecca Vogel, Peter Doohan, et al.
Psychiatry Research
|
May 17, 2015
Erythrocyte polyunsaturated fatty acid levels in young people at ultra-high risk for psychotic disorder and healthy adolescent controls
Simon M Rice, Miriam R Schäfer, Claudia Klier, et al.
Frontiers in Psychiatry
|
June 16, 2020
Commentary: Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence)
Barnaby Nelson, G Paul Amminger, Andrew Thompson, et al.
Biological Psychiatry
|
August 22, 2006
Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study
G Paul Amminger, Gregor E Berger, Miriam R Schäfer, et al.
Current Opinion in Psychiatry
|
June 7, 2007
Age of onset of mental disorders: a review of recent literature
Ronald C Kessler, G Paul Amminger, Sergio Aguilar-Gaxiola, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
|
April 5, 2017
Novel biotherapies are needed in youth mental health
G Paul Amminger, Maximus Berger, Simon M Rice, et al.
Schizophrenia Research
|
September 19, 2012
The Community Assessment of Psychic Experience (CAPE) questionnaire as a screening-instrument in the detection of individuals at ultra-high risk for psychosis
Nilufar Mossaheb, Jana Becker, Miriam R Schaefer, et al.
Schizophrenia Research
|
September 11, 2012
Social cognition in clinical "at risk" for psychosis and first episode psychosis populations
Andrew Thompson, Alicia Papas, Cali Bartholomeusz, et al.
Early Intervention in Psychiatry
|
October 28, 2014
Indicated prevention with long-chain polyunsaturated omega-3 fatty acids in patients with 22q11DS genetically at high risk for psychosis. Protocol of a randomized, double-blind, placebo-controlled treatment trial
Marco Armando, Franco De Crescenzo, Stefano Vicari, et al.
Page
of 20